AUS
NZ
UK
CA
USA
IND
Highlights
FY2022 posed several challenges to the ASX 200.
The benchmark ASX 200 index shed 10.19% in FY2022.
There were ETFs which witnessed losses of over 40%.
The financial year 2022 which finished on 30 June 2022 posed several challenges to the Australian stock market. The benchmark ASX 200 index shed 10.19% in FY2022, showing the extent of weakness. Not only stocks but also exchange-traded funds (ETFs) exhibited such weakness during the fiscal year under review. There were ETFs which witnessed losses of over 40%.
ETFs are otherwise considered safe investments which attract fewer broker commissions. Investors can access leading global companies with single investment and lower costs via ETFs.
On this note, let’s discuss the five worst performing ASX-listed ETFs in the financial year 2022.
BetaShares S&P/ASX Australian Technology ETF (ASX:ATEC)
ATEC provides exposure to ASX tech firms operating in segments such as information technology, consumer electronics, medical technology, etc. Xero Ltd (ASX:XRO) and Carsales.com Ltd (ASX:CAR) are a few firms which are a part of the ETF.
Meanwhile, in FY2022, BetaShares S&P/ASX Australian Technology ETF units shed a 35.7% on their value.
BetaShares Cloud Computing ETF (ASX:CLDD)
The ETF tracks the performance of the index that provides access to top firms in the cloud computing industry. Zoom Video Communications and Netflix are a few companies which are a part of the ETF.
In FY2022, BetaShares Cloud Computing ETF units shed 35.79% on their value.
BetaShares Global Robotics and Artificial Intelligence ETF (ASX:RBTZ)
RBTZ tracks the performance of the index that provides access to companies operating in robotics and AI products and services. The ETF lost 36.01% in FY2022.
ETFS S&P Biotech ETF (ASX:CURE)
The fund is focused on US biotechnology firms. Novavax, Twist Bioscience and Arrowhead Pharmaceuticals are a few firms which are a part of the fund. The fund shed 40.51% in value in FY2022.
ETFS Ultra Long NASDAQ 100 Hedge Fund (ASX:LNAS)
The ETF tracks the US NASDAQ-100 and provides access to 100 of the leading NASDAQ-listed firms. However, LNAS has a leverage nature as it is specially designed to amplify the gains or losses of the NASDAQ-100 index. In FY2022, the weakness in NASDAQ seeped into the ETF as well and it shed 49.99%.
